JDM Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-63
Closed -$1.82K 403
2024
Q3
$1.82K Buy
+63
New +$1.84K ﹤0.01% 257
2023
Q2
Sell
-557
Closed -$22.7K 219
2023
Q1
$22.7K Sell
557
-290
-34% -$12.5K 0.02% 95
2022
Q4
$43.4K Buy
+847
New +$40.6K 0.04% 70

Other funds holding PFE

JDM Financial Group's PFE Position: Q4 2024 in Review

JDM Financial Group sold out of Pfizer (PFE) in Q4 2024, closing a stake of 63 shares — an estimated $1.82K sold.

JDM Financial Group first reported a position in PFE in Q4 2022 and held it in 3 quarters. The position peaked at $43.4K in Q4 2022. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • JDM Financial Group reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • JDM Financial Group sold 63 Pfizer shares in Q4 2024, an estimated $1.82K.
  • JDM Financial Group first reported a position in Pfizer in Q4 2022 and held it in 3 quarters.
  • JDM Financial Group's Pfizer position peaked at $43.4K in Q4 2022.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on JDM Financial Group's 13F filing for Q4 2024, filed 18 Feb 2025.